Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of a Weight Management Program

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Nestlé
ClinicalTrials.gov Identifier:
NCT00888251
First received: April 24, 2009
Last updated: September 21, 2011
Last verified: September 2011
  Purpose

This retrospective chart review and data abstraction will evaluate and quantify the effectiveness of a comprehensive weight management program. The hypothesis is that the program will positively affect weight, weight-related comorbidities and medication use.


Condition Intervention
Obesity
Other: Comprehensive weight management program

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: A Multicenter, Retrospective Study to Evaluate the Effectiveness of the OPTIFAST Weight Management Program

Resource links provided by NLM:


Further study details as provided by Nestlé:

Enrollment: 153
Study Start Date: March 2009
Study Completion Date: July 2009
Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Comprehensive weight management program Other: Comprehensive weight management program
Full meal replacement, behaviorial modification, medical monitoring, exercise.
Other Name: OPTIFAST Program

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

OPTIFAST Program participants

Criteria

Inclusion Criteria:

  • Records of the first 40 study center participants who enrolled in the OPTIFAST Program from January 1, 2006 through June 30, 2006
  • Records of subjects who completed the active weight loss phase of the program
  • Records where data is available through the transitional phase of the program

Exclusion Criteria:

  • Concurrent use of appetite suppressants or other weight loss medications
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00888251

Locations
United States, Indiana
Lutheran Weight Management Center
Fort Wayne, Indiana, United States, 46804
United States, Iowa
Mercy Center for Weight Reduction
Des Moines, Iowa, United States, 50309
United States, Michigan
Sparrow Weight Management Center
East Lansing, Michigan, United States, 48823
United States, Ohio
Jewish Hospital Weight Management Center
Cincinnati, Ohio, United States, 45236
Sponsors and Collaborators
Nestlé
  More Information

No publications provided

Responsible Party: Nestlé
ClinicalTrials.gov Identifier: NCT00888251     History of Changes
Other Study ID Numbers: 08.27.CLI
Study First Received: April 24, 2009
Last Updated: September 21, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Nestlé:
Obesity
Meal replacement
Obesity treatment
Weight management

Additional relevant MeSH terms:
Obesity
Body Weight
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms

ClinicalTrials.gov processed this record on November 25, 2014